mvvp banner red border
Home The Team Portfolio Limited Partners Co-Investors News Articles Contact Us

MVVP logo




A San Diego-based startup biotech company founded by Andrew Young, M.D., Ph.D. developing novel therapeutic treatments for diabetes and obesity. A proof of concept human clinical trial was completed successfully in 2009. The Series A financing was led by Mesa Verde Venture Partners.       


A Utah-based biomarker discovery company focusing on novel, patentable diagnostic testing tools and processes with a focus on the commercialization of diagnostics for Autism and Multiple Sclerosis. A $5.8 million Series A round was led by Sanderling Ventures and vSpring Capital.      

Elevation Pharmaceuticals

A San Diego-based specialty pharmaceutical company aimed at reformulation of an existing COPD drugs, delivered in a nebulized format. Mesa Verde lead a convertible note financing at a discount into the Series A round of $30 million led by Canaan Partners. In September 2012, Elevation was acquired for up to $430 million by Sunovian.       


A Tucson, Arizona and San Diego-based company developing advanced and innovative infusion pump technology for fluid delivery systems based upon electro-activated polymers. Mesa Verde participated in the Series A financing.       


A San Diego-based company that develops and offers innovative technologies that stabilize biological materials at room temperature. Mesa Verde participated in the Series C financing as the company's first institutional investor.      

Executives of the fragrance replica watches purveyor Elizabeth Arden (NASDAQ:RDEN) may chanel replica not say it, but they've found replica handbags themselves like the banished duke in replica louis vuitton a forest where he feels "the penalty of Adam chanel replica," the chill wind and other natural discomforts he deems "counselors that feelingly replica handbags persuade me what I am."


An Albuquerque and San Diego-based discovery driven, patient focused CLIA registered molecular diagnostics laboratory.  Exagen has a growing menu of proprietary, largely internally developed genomic tests to enable more accurate diagnosis of Lupus and Rheumatoid Arthritis. Mesa Verde participated in the Series A and B financing.